Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway.
about
Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancerA critical dose of doxorubicin is required to alter the gene expression profiles in MCF-7 cells acquiring multidrug resistanceMolecular mechanisms of drug resistance in single-step and multi-step drug-selected cancer cells.Regulation of hepatic ABCC transporters by xenobiotics and in disease states.Therapeutic resistance in lung cancer.Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistanceABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer.The role of cytokines in the regulation of drug disposition: extended functional pleiotropism?Cisplatin induces expression of drug resistance-related genes through c-jun N-terminal kinase pathway in human lung cancer cells.Astragaloside Ⅳ reduces the expression level of P-glycoprotein in multidrug-resistant human hepatic cancer cell lines.External Qi of Yan Xin Qigong induces cell death and gene expression alterations promoting apoptosis and inhibiting proliferation, migration and glucose metabolism in small-cell lung cancer cells.Elevated reactive oxygen species but not glutathione regulate mercury resistance to AML-2/DX100 cells.Possible Role of microRNA-122 in Modulating Multidrug Resistance of Hepatocellular Carcinoma.
P2860
Q28481849-7A52F04E-98F3-4F28-B135-EF8D2F17F748Q28543175-DCEAB5F9-31FD-457E-B84A-1469AE9FB80BQ34996536-15532AC0-8ECB-4879-9FA0-8FFED9DEBA2EQ35690177-FD93BC04-F321-45C9-B10F-66801ED9744EQ36609767-849D1574-8829-4F88-9DE2-1B2BB98F5607Q37478653-92E40364-281E-4257-A50A-9603797680DBQ37595188-931EB73A-75DE-4391-9222-3C17E3E67A90Q37836908-5CA043FC-88D5-4C7B-A88F-DCFBA4E25771Q38700781-9DD13285-284E-42E8-BE33-9ECF97C805B7Q39010827-A5A2AA4B-8020-4F42-A0D7-DFF8F2FD455DQ39429668-84E0C94C-3D51-4206-9922-F7A0DFD0C64DQ40228215-EC1DF74D-53D5-438F-970E-94CFAD3A3C55Q49679382-8644C819-83C2-4F2E-B90F-267F93E70C67
P2860
Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Doxorubicin induces expression ...... jun N-terminal kinase pathway.
@en
Doxorubicin induces expression ...... jun N-terminal kinase pathway.
@nl
type
label
Doxorubicin induces expression ...... jun N-terminal kinase pathway.
@en
Doxorubicin induces expression ...... jun N-terminal kinase pathway.
@nl
prefLabel
Doxorubicin induces expression ...... jun N-terminal kinase pathway.
@en
Doxorubicin induces expression ...... jun N-terminal kinase pathway.
@nl
P2093
P2860
P356
P1476
Doxorubicin induces expression ...... jun N-terminal kinase pathway.
@en
P2093
Atsushi Muraguchi
Chie Shinoda
Eiji Sugiyama
Hirofumi Oda
Junichi Dohkan
Kouichirou Shinoda
Koutarou Miyabayashi
Masashi Kobayashi
Muneharu Maruyama
Ryuji Hayashi
P2860
P356
10.1002/IJC.21094
P577
2005-10-01T00:00:00Z